Literature DB >> 3668072

Continuous thoracic epidural analgesia for the control of pain in myocardial infarction.

P Toft1, A Jorgensen.   

Abstract

Continuous thoracic epidural infusion of bupivacaine 0.25% for the relief of pain in acute myocardial infarction (AMI) was studied. The method was only employed for patients, who could not obtain adequate pain relief by parenteral opioid analgesics without unacceptable respiratory depression and/or emesis. The method was effective in controlling pain. The systolic blood pressure was reduced significantly, while the diastolic blood pressure and the heart rate did not change.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3668072     DOI: 10.1007/bf00257681

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  10 in total

Review 1.  Editorial: Analgesia in myocardial infarction.

Authors:  F Kerr; K W Donald
Journal:  Br Heart J       Date:  1974-02

2.  Analgesics in the acute phase of myocardial infarction.

Authors:  E L Alderman
Journal:  JAMA       Date:  1974-09-16       Impact factor: 56.272

3.  Relief of pain in chest injury.

Authors:  J Gibbons; O James; A Quail
Journal:  Br J Anaesth       Date:  1973-11       Impact factor: 9.166

4.  The role of morphine in acute myocardial infarction.

Authors:  D Todres
Journal:  Am Heart J       Date:  1971-04       Impact factor: 4.749

5.  Pain relief in myocardial infarction after continuous epidural morphine analgesia.

Authors:  M Skoeld; L Gillberg; O Ohlsson
Journal:  N Engl J Med       Date:  1985-03-07       Impact factor: 91.245

6.  Intrathecal morphine for the control of the pain of myocardial infarction.

Authors:  V Pasqualucci; G Moricca; P Solinas
Journal:  Anaesthesia       Date:  1981-01       Impact factor: 6.955

7.  Circulatory changes during high thoracic epidural anaesthesia--influence of sympathetic block and of systemic effect of the local anaesthetic.

Authors:  M Wattwil; A Sundberg; A Arvill; C Lennquist
Journal:  Acta Anaesthesiol Scand       Date:  1985-11       Impact factor: 2.105

8.  Analgesic treatment with levomepromazine in acute myocardial infarction. A randomized clinical trial.

Authors:  O Davidsen; O Lindeneg; M Walsh
Journal:  Acta Med Scand       Date:  1979

9.  Göteborg Metoprolol Trial: effects on chest pain.

Authors:  A Richterova; J Herlitz; S Holmberg; K Swedberg; F Waagstein; A Waldenström; A Vedin; B Wennerblom; C Wilhelmsson; A Hjalmarson
Journal:  Am J Cardiol       Date:  1984-06-25       Impact factor: 2.778

10.  Management of fifty cases of chest injury with a regimen of epidural bupivacaine and morphine.

Authors:  A P Rankin; R E Comber
Journal:  Anaesth Intensive Care       Date:  1984-11       Impact factor: 1.669

  10 in total
  5 in total

Review 1.  [Cardioprotection by thoracic epidural anesthesia? : meta-analysis].

Authors:  A Gauss; S K Jahn; L H J Eberhart; W Stahl; M Rockemann; M Georgieff; F Wagner; R Meierhenrich
Journal:  Anaesthesist       Date:  2011-10       Impact factor: 1.041

2.  [Influence of postoperative pain on morbidity and mortality.].

Authors:  W Seeling; M Rockemann
Journal:  Schmerz       Date:  1993-06       Impact factor: 1.107

3.  Anaesthesia for coronary artery bypass surgery supplemented with subarachnoid bupivacaine and morphine: a report of 18 cases.

Authors:  R J Kowalewski; C L MacAdams; C J Eagle; D P Archer; B Bharadwaj
Journal:  Can J Anaesth       Date:  1994-12       Impact factor: 5.063

4.  Excision of sympathetic ganglia and the rami communicantes with histological confirmation offers better early and late outcomes in Video assisted thoracoscopic sympathectomy.

Authors:  Sridhar Rathinam; Prakash Nanjaiah; Sivakumar Sivalingam; Pala B Rajesh
Journal:  J Cardiothorac Surg       Date:  2008-08-13       Impact factor: 1.637

5.  Effects of thoracic epidural analgesia on plasma cAMP and cGMP levels in patients with heart failure.

Authors:  Qing-Shu Li; Feng-Qi Liu
Journal:  J Cardiothorac Surg       Date:  2013-11-26       Impact factor: 1.637

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.